Medtronic received information via literature regarding the outcomes in patients following the ross procedure using stentless porcine roots in the pulmonary position.All data were collected from single center between march 1992 and february 2011.The study population included 61 patients (predominantly male; mean age 38 years), 38 of which were implanted with medtronic freestyle bioprosthetic valves (no serial numbers provided).Among all patients, three deaths occurred within 30 days post implant due to: multi-organ failure resulting from endocarditis present at baseline (2 cases) and hemorrhagic stroke (1 case).During the follow-up period, 2 late deaths occurred due to: cirrhosis (1 case) and suicide (1 case).Multiple manufacturers were noted in the literature; based on the available information, medtronic product was directly associated with the deaths.Among all patients, adverse events included: autograft reoperation (4 reoperations were due to significant insufficiency, 1 was due to dilatation over 50 mm with significant regurgitation, and 1 was due to proximal anastomosis dehiscence).It was reported that no abnormalities were present on the stentless roots during each reoperation.Additional adverse events included: mild-moderate-severe regurgitation and elevated gradients.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|